핵의학

본문글자크기
  • 2022년 07월호
    [Cancer Cell Int.] Multi-omics analysis revealed TEK and AXIN2 are potential biomarkers in multifocal papillary thyroid cancer

    부산대병원 / 김가현, 허혜진, 강지완, 김윤학*, 박경준*

  • 출처
    Cancer Cell Int.
  • 등재일
    2022 May 12
  • 저널이슈번호
    22(1):185. doi: 10.1186/s12935-022-02606-x.
  • 내용

    바로가기  >

    Abstract
    Background: Papillary thyroid carcinoma (PTC), the most common endocrine cancer, accounts for 80-85% of all malignant thyroid tumors. This study focused on identifying targets that affect the multifocality of PTC. In a previous study, we determined 158 mRNAs related to multifocality in BRAF-mutated PTC using The Cancer Genome Atlas.

    Methods: We used multi-omics data (miRNAs and mRNAs) to identify the regulatory mechanisms of the investigated mRNAs. miRNA inhibitors were used to determine the relationship between mRNAs and miRNAs. We analyzed the target protein levels in patient sera using ELISA and immunohistochemical staining of patients' tissues.

    Results: We identified 44 miRNAs that showed a negative correlation with mRNA expression. Using in vitro experiments, we identified four miRNAs that inhibit TEK and/or AXIN2 among the target mRNAs. We also showed that the downregulation of TEK and AXIN2 decreased the proliferation and migration of BRAF ( +) PTC cells. To evaluate the diagnostic ability of multifocal PTC, we examined serum TEK or AXIN2 in unifocal and multifocal PTC patients using ELISA, and showed that the serum TEK in multifocal PTC patients was higher than that in the unifocal PTC patients. The immunohistochemical study showed higher TEK and AXIN2 expression in multifocal PTC than unifocal PTC.

    Conclusions: Both TEK and AXIN2 play a potential role in the multifocality of PTC, and serum TEK may be a diagnostic marker for multifocal PTC.

     

     

    Affiliations

    Ga Hyun Kim #  1 , Hye Jin Heo #  2 , Ji Wan Kang #  1 , Eun-Kyung Kim  2 , Seung Eun Baek  2 , Keunyoung Kim  3 , In Joo Kim  3 , Sunghwan Suh  4 , Byung-Joo Lee  5 , Yun Hak Kim #  6   7   8 , Kyoungjune Pak #  9
    1 Interdisciplinary Program of Genomic Data Science, Pusan National University, Yangsan, Republic of Korea.
    2 Department of Anatomy, School of Medicine, Pusan National University, Yangsan, Republic of Korea.
    3 Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
    4 Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
    5 Department of Otorhinolaryngology-Head and Neck Surgery, Pusan National University Hospital, Busan, Republic of Korea.
    6 Department of Anatomy, School of Medicine, Pusan National University, Yangsan, Republic of Korea. yunhak10510@pusan.ac.kr.
    7 Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. yunhak10510@pusan.ac.kr.
    8 Department of Biomedical Informatics, School of Medicine, Pusan National University, Yangsan, Republic of Korea. yunhak10510@pusan.ac.kr.
    9 Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. ilikechopin@me.com.
    # Contributed equally.

  • 키워드
    BRAF mutation; Multi-omics; Multifocality; Papillary thyroid carcinoma.
  • 덧글달기
    덧글달기
       IP : 18.118.16.229

    등록